STEMCELLS, INC.

StemCells, Inc. Achieves Spinal Cord Injury Milestone With First Neural Stem Cell Transplant Into Patient With Sensory Function Below the Level of Injury

StemCells, Inc. to Present at Neurodegenerative Conditions Research and Development Conference

StemCells falls 3.4%

StemCells, Inc. Provides Additional Comments on Recent Awards From the California Institute for Regenerative Medicine

Biotech Industry Looks to Benefit From New Legislation Passed to Help Speed Up FDA Review Process

A tiny step forward for spinal cord injuries

StemCells awarded $20M from CIRM for Alzheimer's disease program

StemCells, Inc. Awarded $20 Million From the California Institute for Regenerative Medicine for Alzheimer's Disease Program

StemCells, Inc. CEO Discusses Interim 6-Month Data From Spinal Cord Injury Trial - Call Transcript

5 Speculative Biomedical Stocks Under $10: StemCells, Arena Pharmaceuticals, Dendreon, Complete Genomics, Idenix (NAS,NAS:STEM,ARNA)